Validation of a predictive survival model in Italian patients with cystic fibrosis

Journal of Cystic Fibrosis

Volumn 11, Issue 1, 2012, Pages 24-29

  Buzzetti, Roberto ^a   Alicandro, Gianfranco ^b   Minicucci, Laura ^c   Notarnicola, Sara ^c   Furnari, Maria Lucia ^d   Giordano, Gabriella ^d   Lucidi, Vincenzina ^e   Montemitro, Enza ^e   Raia, Valeria ^f   Magazzú, Giuseppe ^g   Vieni, Giuseppe ^h   Quattrucci, Serena ⁱ   Ferrazza, Alessandro ⁱ   Gagliardini, Rolando ^j   Cirilli, Natalia ^j   Salvatore, Donatello ^k   Colombo, Carla ^b  

^a Italian Foundation for Research on Cystic Fibrosis   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d Ospedale dei Bambini G Di Cristina   (Italy)

^e BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^f UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^g UNIVERSITY OF MESSINA   (Italy)

^h UNIVERSITY OF MESSINA   (Italy)

ⁱ SAPIENZA UNIVERSITY OF ROME   (Italy)

^j Salesi Children's Hospital   (Italy)

^k SAN CARLO HOSPITAL   (Italy)

more..

Author keywords

Cystic fibrosis; Survival models

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA CEPACIA INFECTION; CHILD; CYSTIC FIBROSIS; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRESCHOOL CHILD; SCHOOL CHILD; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SURVIVAL; VALIDATION PROCESS;

ADOLESCENT; CHI-SQUARE DISTRIBUTION; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LOGISTIC MODELS; MALE; PROGNOSIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84855873023     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2011.08.007     Document Type: Article

References (35)

1. Kerem E., Reisman J., Corey M., Canny G.J., Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992, 326(18):1187-1191.
2. Liou T.G., Adler F.R., Fitzsimmons S.C., Cahill B.C., Hibbs J.R., Marshall B.C. Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol 2001, 153(4):345-352.
3. Aigner C., Jaksch P., Seebacher G., Mazhar S., Wisser W., Klepetko W. Cystic fibrosis and lung transplantation-determination of the survival benefit. Wien Klin Wochenschr 2004, 116(9-10):318-321.
4. Augarten A., Akons H., Aviram M., Bentur L., Blau H., Picard E., et al. Prediction of mortality and timing of referral for lung transplantation in cystic fibrosis patients. Pediatr Transplant 2001, 5(5):339-342.
5. Hofer M., Benden C., Inci I., Schmid C., Irani S., Speich R., Weder W., Boehler A. True survival benefit of lung transplantation for cystic fibrosis patients: the Zurich experience. J Heart Lung Transplant 2009, 28(4):334-339.
6. Efrati O., Mei-Zahav M., Rivlin J., Kerem E., Blau H., Barak A., et al. Long term nutritional rehabilitation by gastrostomy in Israeli patients with cystic fibrosis: clinical outcome in advanced pulmonary disease. J Pediatr Gastroenterol Nutr 2006, 42(2):222-228.
7. Hankinson J.L., Odencrantz J.R., Fedan K.B. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 1999, 159:179-187.
8. Lai H.C., Kosorok M.R., Sondel S.A., Chen S.T., FitzSimmons S.C., Green C.G., et al. Growth status in children with cystic fibrosis based on the National Cystic Fibrosis Patient Registry data: evaluation of various criteria used to identify malnutrition. J Pediatr 1998, 132:478-485.
9. Dibley M.J., Goldsby J.B., Staehling N.W., Trowbridge F.L. Development of normalized curves for the international growth reference: historical and technical considerations. Am J Clin Nutr 1987, 46:736-748.
10. Viviani L., Padoan R., Giglio L., Bossi A. The Italian registry for cystic fibrosis: what has changed in the last decade. Epidemiol Prev 2003, 27:91-96.
11. Liou T.G., Adler F.R., Huang D. Use of lung transplantation survival models to refine patient selection in cystic fibrosis. Am J Respir Crit Care Med 2005, 171(9):1053-1059.
12. Lucidi V., Alghisi F., Raia V., Russo B., Valmarana L., Valmarana R., et al. Growth assessment of paediatric patients with CF comparing different auxologic indicators: a multicentre Italian study. J Pediatr Gastroenterol Nutr 2009, 49(3):335-342.
13. Bossi A., Casazza G., Padoan R., Milani S. Assemblea Dei Direttori Dei Centri. What is the incidence of cystic fibrosis in Italy? Data from the National Registry (1988-2001). Hum Biol 2004, 76(3):455-467.
14. Corey M., Farewell V. Determinants of mortality from cystic fibrosis in Canada, 1970-1989. Am J Epidemiol 1996, 143(10):1007-1017.
15. George P.M., Banya W., Pareek N., Bilton D., Cullinan P., Hodson M.E., Simmonds N.J. Improved survival at low lung function in cystic fibrosis: cohort study from 1990 to 2007. BMJ 2011, 342:d1008.
16. Dodge J.A., Lewis P.A., Stanton M., Wilsher J. Cystic fibrosis mortality and survival in the UK: 1947-2003. Eur Respir J 2007, 29:522-526.
17. McKone E.F., Emerson S.S., Edwards K.L., Aitken M.L. Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study. Lancet 2003, 361(9370):1671-1676.
18. Buzzetti R., Salvatore D., Baldo E., Forneris M.P., Lucidi V., Manunza D., et al. An overview of international literature from cystic fibrosis registries: 1. Mortality and survival studies in cystic fibrosis. J Cyst Fibros 2009, 8(4):229-237.
19. Jackson A.D., Daly L., Kelleher C., Marshall B.C., Quinton H.B., Foley L., et al. The application of current lifetable methods to compare cystic fibrosis median survival internationally is limited. J Cyst Fibros 2011, 10(1):62-65.
20. Cystic Fibrosis Foundation Patient Registry Annual Data Report 2008 2008, Cystic Fibrosis Foundation, Bethesda, MD.
21. McCormick J., Mehta G., Olesen H.V., Viviani L., Macek M., Mehta A. Comparative demographics of the European cystic fibrosis population: a cross-sectional database analysis. Lancet 2010, 375(9719):1007-1013. European Registry Working Group.
22. Davis P.B. Cystic fibrosis since 1938. Am J Respir Crit Care Med 2006, 173:475-482.
23. Grasemann H., Ratjen F. Emerging therapies for cystic fibrosis lung disease. Expert Opin Emerg Drugs 2010, 15(4):653-659.
24. Heijerman H., Westerman E., Conway S., Touw D., Döring G. Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: a European consensus. J Cyst Fibros 2009, 8(5):295-315. consensus working group.
25. Moran F., Bradley J.M., Piper A.J. Non-invasive ventilation for cystic fibrosis. Cochrane Database Syst Rev 2009, 1:CD002769.
26. Dodge J.A., Lewis P.A. Cystic fibrosis is no longer an important cause of childhood death in the UK. Arch Dis Child 2005, 90(5):547.
27. Kulich M., Rosenfeld M., Goss C.H., Wilmott R. Improved survival among young patients with cystic fibrosis. J Pediatr 2003, 142:631-637.
28. Finkelstein S.M., Wielinski C.L., Elliott G.R., Warwick W.J., Barbosa J., Wu S.C., Klein D.J. Diabetes mellitus associated with cystic fibrosis. J Pediatr 1988, 112:373-377.
29. Moran A., Dunitz J., Nathan B., Saeed A., Holme B., Thomas W. Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care 2009, 32:1626-1631.
30. Chamnan P., Shine B.S., Haworth C.S., Bilton D., Adler A.I. Diabetes as a determinant of mortality in cystic fibrosis. Diabetes Care 2010, 33(2):311-316.
31. Mayer-Hamblett N., Rosenfeld M., Emerson J., Goss C.H., Aitken M.L. Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality. Am J Respir Crit Care Med 2002, 166(12 Pt 1):1550-1555.
32. Li Z., Kosorok M.R., Farrell P.M., Laxova A., West S.E., Green C.G., et al. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA 2005, 293(5):581-588.
33. Demko C.A., Byard P.J., Davis P.B. Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. J Clin Epidemiol 1995, 48(8):1041-1049.
34. Levy H., Kalish L.A., Cannon C.L., García K.C., Gerard C., Goldmann D., et al. Predictors of mucoid Pseudomonas colonization in cystic fibrosis patients. Pediatr Pulmonol 2008, 43(5):463-471.
35. Goss C.H., Muhlebach M.S. Review: Staphylococcus aureus and MRSA in cystic fibrosis. J Cyst Fibros 2011, [Epub ahead of print].